Description
Neoleukin Therapeutics was a biopharmaceutical company that generated immunotherapies using de novo protein design technology. The firm used computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins to treat serious diseases, including cancer, inflammatory, and autoimmune disorders.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 08-Aug-2019 | $51.6M | 00000 | 0000 | Completed | Generating Revenue/Not Profitable |
1. Early Stage VC | 08-Feb-2019 | 00000 | 00000 | Completed | Generating Revenue/Not Profitable |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
WRF Capital | Venture Capital | Minority | 000 0000 | 000000 0 |